SSX6 Antibody Cat. No.: 25-337

SSX6 Antibody

Specifications

HOST SPECIES: Rabbit

SPECIES REACTIVITY: Human

Antibody produced in rabbits immunized with a synthetic peptide corresponding a region IMMUNOGEN: of human SSX6.

TESTED APPLICATIONS: ELISA, WB

SSX6 antibody can be used for detection of SSX6 by ELISA at 1:1562500. SSX6 antibody can APPLICATIONS: be used for detection of SSX6 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.

POSITIVE CONTROL: 1) Cat. No. 1211 - HepG2 Cell Lysate

PREDICTED MOLECULAR 22 kDa WEIGHT:

Properties

PURIFICATION: Antibody is purified by peptide affinity chromatography method.

CLONALITY: Polyclonal

CONJUGATE: Unconjugated

PHYSICAL STATE: Liquid

October 2, 2021 1 https://www.prosci-inc.com/ssx6-antibody-25-337.html Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% BUFFER: sucrose.

CONCENTRATION: batch dependent

For short periods of storage (days) store at 4˚C. For longer periods of storage, store SSX6 STORAGE CONDITIONS: antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.

Additional Info

OFFICIAL SYMBOL: SSX6

ALTERNATE NAMES: SSX6, dJ54B20.1, SSXP2, psiSSX2

ACCESSION NO.: NP_775493

PROTEIN GI NO.: 27659730

GENE ID: 280657

USER NOTE: Optimal dilutions for each application to be determined by the researcher.

Background and References

SSX6 belongs to the family of highly homologous X (SSX) breakpoint . These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy.The product of this belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint BACKGROUND: proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 have been involved in the t (X;18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of translocation.

REFERENCES: 1) de (2007) Genes Cancer 46 (2), 107-117.

ANTIBODIES FOR RESEARCH USE ONLY.

For additional information, visit ProSci's Terms & Conditions Page.

October 2, 2021 2 https://www.prosci-inc.com/ssx6-antibody-25-337.html